1
|
Alejaldre L, Lemay-St-Denis C, Pelletier JN, Quaglia D. Tuning Selectivity in CalA Lipase: Beyond Tunnel Engineering. Biochemistry 2023; 62:396-409. [PMID: 36580299 PMCID: PMC9851156 DOI: 10.1021/acs.biochem.2c00513] [Citation(s) in RCA: 4] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/01/2022] [Revised: 12/15/2022] [Indexed: 12/30/2022]
Abstract
Engineering studies of Candida (Pseudozyma) antarctica lipase A (CalA) have demonstrated the potential of this enzyme in the selective hydrolysis of fatty acid esters of different chain lengths. CalA has been shown to bind substrates preferentially through an acyl-chain binding tunnel accessed via the hydrolytic active site; it has also been shown that selectivity for substrates of longer or shorter chain length can be tuned, for instance by modulating steric hindrance within the tunnel. Here we demonstrate that, whereas the tunnel region is certainly of paramount importance for substrate recognition, residues in distal regions of the enzyme can also modulate substrate selectivity. To this end, we investigate variants that carry one or more substitutions within the substrate tunnel as well as in distal regions. Combining experimental determination of the substrate selectivity using natural and synthetic substrates with computational characterization of protein dynamics and of tunnels, we deconvolute the effect of key substitutions and demonstrate that epistatic interactions contribute to procuring selectivity toward either long-chain or short/medium-chain fatty acid esters. We demonstrate that various mechanisms contribute to the diverse selectivity profiles, ranging from reshaping tunnel morphology and tunnel stabilization to obstructing the main substrate-binding tunnel, highlighting the dynamic nature of the substrate-binding region. This work provides important insights into the versatility of this robust lipase toward diverse applications.
Collapse
Affiliation(s)
- Lorea Alejaldre
- PROTEO,
The Québec Network for Research on Protein, Function, Engineering
and Applications, https://proteo.ca/en/
- CGCC, Center
in Green Chemistry and Catalysis, Montréal, QC, CanadaG1V 0A6
- Department
of Biochemistry and Molecular Medicine, Université de Montréal, Montréal, QC, CanadaH3T 1J4
| | - Claudèle Lemay-St-Denis
- PROTEO,
The Québec Network for Research on Protein, Function, Engineering
and Applications, https://proteo.ca/en/
- CGCC, Center
in Green Chemistry and Catalysis, Montréal, QC, CanadaG1V 0A6
- Department
of Biochemistry and Molecular Medicine, Université de Montréal, Montréal, QC, CanadaH3T 1J4
| | - Joelle N. Pelletier
- PROTEO,
The Québec Network for Research on Protein, Function, Engineering
and Applications, https://proteo.ca/en/
- CGCC, Center
in Green Chemistry and Catalysis, Montréal, QC, CanadaG1V 0A6
- Department
of Biochemistry and Molecular Medicine, Université de Montréal, Montréal, QC, CanadaH3T 1J4
- Department
of Chemistry, Université de Montréal, Montréal, QC, CanadaH2V 0B3
| | - Daniela Quaglia
- PROTEO,
The Québec Network for Research on Protein, Function, Engineering
and Applications, https://proteo.ca/en/
- CGCC, Center
in Green Chemistry and Catalysis, Montréal, QC, CanadaG1V 0A6
- Department
of Chemistry, Université de Montréal, Montréal, QC, CanadaH2V 0B3
- Department
of Chemistry, Carleton University, Ottawa, ON, CanadaK1S 5B6
| |
Collapse
|
2
|
Chałupka J, Sikora A, Kozicka A, Marszałł MP. Overview: Enzyme-catalyzed Enantioselective Biotransformation of Chiral Active Compounds Used in Hypertension Treatment. CURR ORG CHEM 2020. [DOI: 10.2174/1385272824999201020204256] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
Enzymatic kinetic resolution is one of the methods which allows for the synthesis
of enantiomerically pure various active pharmaceutical ingredients. In contrast to chemical
routes, enzymatic reactions have characteristics, including mild reaction conditions, a few byproducts,
and relatively high activity of the used enzymes. β-adrenolytic drugs are widely
used in the treatment of hypertension and cardiovascular disorders. Due to the fact that β-
blockers possess an asymmetric carbon atom in their structure, they are presented in two
enantiomeric forms. It was reported by many studies that only the (S)-enantiomers of these
drugs possess the desired therapeutic effect, whereas the administration of the racemate may
cause dangerous side effects, such as bronchoconstriction or diabetes. Nevertheless, β-
blockers are still commercially available drugs mainly used in medicine as racemates, whereas there are several
methods that are widely used in order to obtain enantiomerically pure compounds.
Collapse
Affiliation(s)
- Joanna Chałupka
- Department of Medicinal Chemistry, Collegium Medicum in Bydgoszcz, Faculty of Pharmacy, Nicolaus Copernicus University in Toruń, Dr. A. Jurasza 2, 85-089 Bydgoszcz, Poland
| | - Adam Sikora
- Department of Medicinal Chemistry, Collegium Medicum in Bydgoszcz, Faculty of Pharmacy, Nicolaus Copernicus University in Toruń, Dr. A. Jurasza 2, 85-089 Bydgoszcz, Poland
| | - Aleksandra Kozicka
- Department of Medical Genetics, University in Cambridge, Lv 6 Addenbrooke’s Treatment Centre, Cambridge, United Kingdom
| | - Michał Piotr Marszałł
- Department of Medicinal Chemistry, Collegium Medicum in Bydgoszcz, Faculty of Pharmacy, Nicolaus Copernicus University in Toruń, Dr. A. Jurasza 2, 85-089 Bydgoszcz, Poland
| |
Collapse
|